PubMed:18285341 / 918-1007 JSONTXT

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T14","span":{"begin":54,"end":57},"obj":"Glycan_Motif"}],"attributes":[{"id":"A14","pred":"image","subj":"T14","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G19059PI"}],"text":"Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly."}

{"project":"sentences","denotations":[{"id":"T7","span":{"begin":0,"end":89},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly."}

{"project":"Glycan-GlyCosmos","denotations":[{"id":"T7","span":{"begin":54,"end":57},"obj":"Glycan"}],"attributes":[{"id":"A7","pred":"glycosmos_id","subj":"T7","obj":"https://glycosmos.org/glycans/show/G19059PI"},{"id":"A16","pred":"image","subj":"T7","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G19059PI"}],"text":"Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly."}

{"project":"GlyCosmos-GlycoEpitope","denotations":[{"id":"T7","span":{"begin":54,"end":57},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A7","pred":"glycoepitope_id","subj":"T7","obj":"http://www.glycoepitope.jp/epitopes/EP0082"}],"text":"Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly."}

{"project":"sentences","denotations":[{"id":"T7","span":{"begin":0,"end":89},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T7","span":{"begin":0,"end":89},"obj":"Sentence"}],"text":"Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly."}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T7","span":{"begin":54,"end":57},"obj":"Glycan"}],"attributes":[{"id":"A7","pred":"glycosmos_id","subj":"T7","obj":"https://glycosmos.org/glycans/show/G19059PI"},{"id":"A16","pred":"image","subj":"T7","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G19059PI"}],"text":"Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly."}

{"project":"GlyCosmos15-GlycoEpitope","denotations":[{"id":"T7","span":{"begin":54,"end":57},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A7","pred":"glycoepitope_id","subj":"T7","obj":"http://www.glycoepitope.jp/epitopes/EP0082"}],"text":"Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly."}